The additional factors that contribute to the AMPK activation after combined treatment are increased cytokines in these animals, since Il1b, as obesity-related, and Il6, as a muscle energy sensor, contribute to increased AMPK activity [51,52]. The gene discussed is PRKAA1; the disease is Obesity.